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Summary Over the last three decades, knowledge about fundamental and clinical aspects of
the ductus arteriosus has substantially improved, leading to considerable progress in the man-
agement of various cardiac diseases involving the ductus. The identiﬁcation of the mechanisms
regulating ductal patency led to design pharmacological drugs to achieve medical closure of PDA
in premature infants, or inversely to maintain patency in neonates with duct-dependent congen-
ital heart diseases. Concurrently, widespread availability of echocardiography has improved the
detection of congenital PDA, resulting in earlier treatment. Closure of PDA, by either surgery or
transcatheter techniques, can now be achieved safely, resulting in a decrease in the incidence
of severe complications of PDA.
© 2010 Elsevier Masson SAS. All rights reserved.
MOTS CLÉS Résumé Au cours des 30 dernières années, les connaissances des aspects fondamentaux et
Canal artériel
persistant ;
Cardiopathie
congénitale ;
Prématurité
cliniques du canal artériel ont beaucoup progressé, conduisant à une amélioration de la prise en
charge des pathologies cardiaques impliquant le canal artériel. L’identiﬁcation des mécanismes
régulant la perméabilité ductale a permis la mise au point de produits pharmacologiques entraî-
nant une fermeture médicale du canal artériel chez le prématuré, ou au contraire maintenant la
perméabilité ductale chez le nouveau-né atteint d’une cardiopathie ductodépendante. Simul-
tanément, le développement de l’échocardiographie a amélioré la détection du canal artériel
Abbreviations: CVO, combined ventricular output; PDA, patent ductus arteriosus; pO2, partial pressure of oxygen; PGE2,
rostaglandin E2; PVR, pulmonary vascular resistance; SVR, systemic vascular resistance.
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persistant congénital, permettant un traitement plus précoce. La fermeture du canal artériel,
par chirurgie ou par cathétérisme interventionnel, peut maintenant être pratiquée avec un très
faible risque, diminuant ainsi l’incidence des complications sévères du canal artériel persistant.
© 2010 Elsevier Masson SAS. Tous droits réservés.
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effect of PGE2 [3].
Finally, endothelial cells of the ductus produce nitric
oxide, contributing to ductal patency.Anatomy
The ductus arteriosus is a large channel found normally in all
mammalian foetuses, connecting the main pulmonary trunk
with the left-sided descending aorta, about 5 to 10mm dis-
tal to the origin of the left subclavian artery in a full-term
infant. The length of the ductus arteriosus varies and its
diameter is similar to that of the descending aorta.
Embryology
In normal cardiovascular development, the proximal por-
tions of the sixth pair of embryonic aortic arches persist
as the proximal branch pulmonary arteries and the distal
portion of the left sixth arch persists as the ductus arte-
riosus, connecting the main pulmonary trunk with the left
dorsal aorta. Normally, the distal right sixth arch degener-
ates.
Histology
The microscopic structure of the ductus arteriosus is quite
different to that of the adjacent pulmonary trunk or aorta.
Although the wall thickness of these vessels are similar, the
media of the ductus arteriosus consists largely of smooth
muscle cells, instead of the circumferentially arranged lay-
ers of elastic ﬁbres composing the media of the aorta and
the pulmonary artery. Contraction of these smooth muscle
cells results in narrowing of the lumen and shortening of the
ductus arteriosus.
Physiology
Function
In the foetus, gas exchange occurs in the placenta, and not
in the lungs as after birth. There is thus need for only a small
amount of blood in the lungs for nutritional and metabolic
requirements, accounting for only 5 to 10% of the combined
ventricular output (CVO), whereas the right ventricle ejects
about 65% of CVO (Fig. 1). The ductus arteriosus diverts a
major proportion of the right ventricular output, i.e. about
55% of the CVO, away from the high-resistance pulmonary
vascular bed to the low-resistance umbilical-placental cir-
culation.
Regulation of the ductusThe ductus arteriosus is widely patent in the foetus. The fac-
tors considered as agents in maintaining ductal patency in
the foetus include exposure to low partial pressure of oxy-
F
t
t
[en (pO2; 18mmHg in the foetal lamb), circulating or locally
roduced prostaglandins, and local nitric oxide production.
Oxygen has been shown to constrict the ductus arterio-
us in vitro and in vivo [1]. In addition, responsiveness of
he ductus arteriosus to oxygen increases with advancing
estation.
Vasodilator prostaglandins, especially prostaglandin E2
PGE2), play a part in maintaining the patency of
he ductus during foetal and neonatal life [2]. Inhibi-
ion of prostaglandin synthesis, through inhibition of the
nzyme cyclo-oxygenase, results in constriction of the
oetal ductus. After birth, PGE2 is metabolized in the
ungs and its concentration falls rapidly within 3 hours.
urthermore, prostaglandin-induced ductal dilation is devel-
pmentally regulated. The immature ductus produces more
rostaglandin and is also more sensitive to the relaxantigure 1. Percentages of combined ventricular output that return
o the foetal heart, that are ejected by each ventricle and ﬂow
hrough the main vascular channels in a late gestation lamb.
32].
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echanisms of normal closure
n full-term infants, postnatal closure of the ductus is
ffected in two phases: smooth muscle constriction pro-
uces ‘‘functional’’ closure of the lumen of the ductus
ithin 18 to 24 hours after birth; and ‘‘anatomical’’ occlu-
ion of the lumen occurs over the next few days or weeks.
After delivery, there is an increase in arterial pO2, a drop
n circulating PGE2 and a drop in blood pressure within the
umen of the ductus (caused by the drop in pulmonary vas-
ular resistance). All these events promote constriction of
he ductus. This initial functional constriction of the ductus
rteriosus is responsible for its ultimate anatomical closure;
he loss of luminal blood ﬂow produces a zone of hypoxia
n the muscle media of the ductus necessary for irreversible
natomical closure [4]. This hypoxic zone is associated with
ocal induction of smooth muscle cell death in the media and
ocal production of hypoxia-inducible growth factors. These
rowth factors stimulate endothelial proliferation, leading
o extensive neointimal thickening. In addition, the pro-
ound vessel wall hypoxia inhibits endogenous prostaglandin
nd nitric oxide production and prevents subsequent reopen-
ng. The endothelium proliferation results in ﬁbrosis and
ermanent seal, producing a ﬁbrous band known as the lig-
mentum arteriosum in 2 to 3 weeks.
atent ductus arteriosus
pidemiology — risk factors
he incidence of PDA in term infants is about 1 in 2000 births,
ccounting for 5 to 10% of all congenital heart disease. The
emale to male ratio is ∼2:1.
In contrast to premature infants, in whom PDA is due to
evelopmental immaturity, PDA in term infants results from
signiﬁcant structural abnormality. It occurs with increased
requency in several genetic syndromes, including chromo-
omal aberrations and single gene mutations. Although most
ases of PDA are seemingly sporadic, many are believed
o be due to multifactorial inheritance, with the require-
ent of genetic predisposition and an environmental trigger
hat occurs at a vulnerable time [5]. The genetic mecha-
isms of PDA in some patients may be autosomal recessive
nheritance with incomplete penetrance [6]. The precise
echanisms of how these genetic abnormalities result in
DA are not clear. Genetic studies suggest that the abnor-
alities in Char syndrome (an inherited disorder with PDA)
esult from derangement of neural crest derivatives [7].
In addition to these genetic factors, infection and envi-
onmental factors, such as congenital rubella, may play a
ole.
etiology
n a breed of dogs with hereditary PDA, the media of the
uctus has an abnormal structure, with smooth muscle cells
artly replaced by collagen and elastic ﬁbres [8]. In this ani-
al model, the endothelial cells fail to separate normally
rom the internal elastic lamina. These histological features
esemble those of the PDA in humans, suggesting a similar
athogenesis.
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athophysiology
he haemodynamic impact of PDA depends on the magni-
ude of the left-to-right shunting, determined by the size
f the ductus and the relationship between systemic and
ulmonary vascular resistance (PVR), and on left ventricular
erformance. After birth, the rise in systemic vascular resis-
ance and the fall in PVR results in left-to-right shunting,
ncreasing over the ﬁrst weeks of life. Left-to-right shunt-
ng through the ductus results in pulmonary overcirculation
nd left ventricular overload. Increased pulmonary blood
ow leads to increased pulmonary ﬂuid volume, decreased
ung compliance and increased work of breathing. Although
ncommon, pulmonary oedema may occur.
Increased ﬂow returning to the left heart results in left
entricular overload. The left ventricle is able to handle the
ncreased volume load up to a shunting of 50% of its output.
bove that limit, left ventricular failure may occur.
In the long term, pulmonary hypertension resulting from
ulmonary overcirculation may induce progressive mor-
hological changes in the pulmonary vasculature. These
hanges, including arteriolar medial hypertrophy, intimal
roliferation and eventual obliteration of pulmonary arte-
ioles and capillaries, lead to increased PVR. This form of
ulmonary hypertension as a consequence of left-to-right
hunt is called Eisenmenger’s syndrome. When PVR exceeds
ystemic vascular resistance, ductal shunting is reversed and
ecomes right-to-left.
linical manifestations
he clinical picture varies depending on the magnitude
f the shunting. In the most severe forms, infants with a
oderate or large PDA will present with progressive conges-
ive heart failure, often within 8 to 10 weeks after birth.
ost patients with small to moderate left-to-right shunt
ompensate well throughout childhood, but may ﬁnally
evelop congestive heart failure secondary to chronic vol-
me overload in adulthood, starting in the third decade.
ome patients with a small ductus may remain completely
symptomatic. In those patients, PDA is usually diagnosed
uring evaluation of a heart murmur. Since the introduc-
ion of echocardiography, very small ductus, referred to
s ‘‘silent’’ ductus, may be detected incidentally by an
chocardiogram performed for another purpose.
Physical examination ﬁndings also vary. Typically, a con-
inuous murmur is heard, located at the upper left sternal
order, referred to as a ‘‘machinery’’ murmur. It radiates
own the left side of the sternum and into the back, and a
hrill may be present. If the shunt is moderate or large, the
ulse is rapid and bounding and pulse pressure is increased.
epatomegaly is usually noted.
In the severe forms presenting during infancy, the symp-
oms of cardiac failure will gradually subside after 3 to 6
onths, as pulmonary vascular resistance increases. The
ime course of subsequent changes varies between 2 to 3
ears and late adolescence or even early adult life. In the
ate stages of Eisenmenger’s syndrome, the patients are
yanotic and may have differential cyanosis, more marked
ith exertion. There is no murmur during systole or dias-
ole because shunting is minimal. Auscultation may reveal
diastolic murmur of pulmonary regurgitation and/or a
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holosystolic murmur from tricuspid regurgitation. The inten-
sity of the pulmonic component of the second heart sound
is increased.
Electrocardiogram
The electrocardiogram shows left ventricular hypertrophy
and left atrial enlargement in patients with moder-
ate or large PDA. In patients with smaller shunts, the
electrocardiogram is usually normal. In advanced stages
(Eisenmenger’s syndrome), the electrocardiogram shows
nonspeciﬁc signs of pulmonary hypertension.
Echocardiogram
The echocardiogram is the procedure of choice to conﬁrm
the diagnosis, evaluate the impact of a PDA, and assess
the presence of associated lesions (Fig. 2A). The ductus can
be imaged throughout its length using a high left paraster-
nal view, allowing evaluation of ductal size and geometry.
M-mode studies provide an assessment of left atrial and ven-
tricular size, which gives some idea of the magnitude of
the shunt. In patients with moderate or large PDA, the left
atrium and left ventricle are enlarged, whereas they are nor-
mal in patients with smaller PDA. A left atrium/aorta ratio
> 2 is considered to be a reliable marker of a haemodynam-
ically signiﬁcant ductal shunt.
Colour Doppler is a very sensitive technique to detect
even tiny ductus, showing retrograde high-velocity ﬂow
entering the pulmonary artery trunk near the origin of the
left pulmonary artery (Fig. 2B). On the other hand, when
colour Doppler shows the presence of bidirectional or pure
right-to-left shunting, it indicates elevated pulmonary vas-
cular resistance. However, in these patients, the PDA may be
difﬁcult to visualize, even if it is large. The most prominent
echocardiographic features in this setting may be enlarge-
ment of the right cardiac chambers, septal ﬂattening, right
P
T
s
Figure 2. Echocardiogram showing patent ductus arteriosus. A: two-
ﬂow showing retrograde ﬂow in the pulmonary trunk. C: spectral Dopp
pressure gradient of 59mmHg.581
entricular hypertrophy or high-velocity tricuspid and/or
ulmonary regurgitation. These ﬁndings should prompt to
ook for a patent ductus. Contrast echocardiography per-
ormed with saline and microbubbles may be helpful in this
etting.
Except when the ductus is very long and tortuous,
ulmonary artery systolic and diastolic pressures can be
stimated approximately by measurement of the pressure
radient between the aorta and the pulmonary artery,
erived from the application of the modiﬁed Bernouilli equa-
ion to the Doppler velocity of the ductal ﬂow (Fig. 2C) [9].
atural history and complications
pontaneous closure of the ductus may occur even beyond
nfancy, at a rate of 0.6% per year, varying with the ductal
ize.
Congestive heart failure in adulthood, starting around the
hird decade, may result from chronic left ventricular over-
oad, even in patients with moderate left-to-right shunt.
Eisenmenger’s disease, when it occurs, usually results
rom a moderate to large shunt causing chronic pulmonary
verload [10], although in some cases pulmonary vascular
hanges appear to be a primary disease coinciding with the
resence of a small ductus [11].
The incidence of infective endarteritis, which was
eported to be 1% per year, has fallen dramatically over
he last two decades, secondary to improved dental care,
idespread use of antibiotics and a general reduction in
he occurrence of infections in the population [12]. In
eveloping countries, the incidence of endarteritis remains
igniﬁcantly high [13].rinciples of management
echniques for PDA closure are either surgery or tran-
catheter closure. Surgical ligation is performed by
dimensional image of patent ductus arteriosus. B: colour Doppler
ler of continuous ductal ﬂow, enabling measurement of a systolic
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left thoracotomy without cardiopulmonary bypass.
omplications are rare and include bleeding, pneumoth-
rax, recurrent laryngeal nerve palsy and chylothorax.
ranscatheter closure of the PDA is more recent. The ﬁrst
xperience was reported by Portsmann et al. in 1967, fol-
owed by Rashkind et al. with the use of a double-umbrella
evice [14]. These devices required the use of large intro-
ucer sheaths and left a signiﬁcant number of residual
hunts. Subsequently, the closure by coils that reduced the
equired catheter size became the technique of choice for
mall to moderate ductus [15]. More recently, the use of the
mplatzer duct occluder made possible the transcatheter
losure of large shunts [16].
Currently, most patients with PDA can have safe, success-
ul transcatheter closure above 5 kg. Rare complications are
mbolization of device (usually retrievable), device protru-
ion causing obstruction of the descending aorta or of the
eft pulmonary artery, and haemolysis resulting from high-
elocity residual shunting.
ndications for closure
ymptomatic infants who do not respond rapidly to medi-
al anticongestive treatment should undergo PDA closure,
y surgery if under 5 kg and by transcatheter technique oth-
rwise.
In asymptomatic patients with signiﬁcant left-to-right
hunt, PDA closure is indicated to prevent complications, but
an be delayed beyond infancy if pulmonary artery pressure
s less than half of systemic arterial pressure.
In patients with markedly increased PVR and those with
xed pulmonary hypertension emphasized by right-to-left
hunt (Eisenmenger’s syndrome), PDA closure is contraindi-
ated. Pulmonary hypertension in this form progresses
ndependently from the shunt and once pulmonary vascular
esistance overtakes systemic vascular resistance (SVR), the
xistence of a right-to-left shunt delays fall of systemic out-
ow and right ventricle failure. In patients with moderately
ncreased PVR (> 6 Wood units/m2, ratio PVR/SVR > 0.35),
he decision is difﬁcult and is based on the pulmonary
esponse to vasoreactivity testing (inhaled nitric oxide or
xygen) and sometimes on lung biopsy.
The indications for closure in patients with silent ductus
emain controversial. In these patients, the main argument
o close the ductus is the prevention of endarteritis. How-
ver, the risk is considered so low that antibiotic prophylaxis
s no longer recommended by the most recent guidelines for
atients with PDA. Because closure can be achieved with
inimal morbidity and mortality, some authors advocate
outine closure of any PDA [17], whereas such an approach
ppears unreasonable to others [18].
DA in the premature infant
echanisms for patency
n preterm infants, the ductus frequently remains open for
any days after birth. Several factors may explain this
elayed closure. First, as stated above, the immature ductus
as a high threshold of response to oxygen. In addition, the
mmature ductus is more sensitive to the vasodilating effects
t
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f PGE2 and nitric oxide. Furthermore, the circulating lev-
ls of PGE2 are particularly high in the premature infant
ecause they fail to be metabolized completely by immature
ungs. Even when the ductus does constrict, this constriction
s not sufﬁcient to produce the profound media hypoxia nec-
ssary for anatomical closure. Subsequent reopening of the
uctus may ensue. All these elements account for the fact
hat 70 to 80% of the infants with a birth weight below 1000 g
ave a PDA [19].
athophysiology
n premature infants, the rapid postnatal fall in vascular pul-
onary resistance results in a left-to-right shunt through
he unconstricted ductus. The consequences of this shunt
re twofold: pulmonary overcirculation and low systemic
utput.
Respiratory distress syndrome due to lung immaturity
s a common occurrence in premature infants. It usually
mproves after 2 to 3 days, but ductal shunting may alter
ulmonary compliance, causing a secondary increase in
entilatory requirements. Increased permeability of the
mmature capillaries results in pulmonary oedema and
ometimes leads to pulmonary haemorrhage, a rare but life-
hreatening event, usually occurring within 72 hours of life
20]. Epidemiologic studies have also found an association
etween PDA and a higher incidence of chronic lung dis-
ase, the long-term pulmonary complication of prematurity
21].
In contrast to full-term patients, systemic output may
e compromised in premature patients with a PDA. In
xperimental studies in lambs, Clyman et al. demonstrated
hat normal systemic blood ﬂow is maintained in full-term
nimals with left-to-right shunts of as much as 75% of
eft ventricular output, whereas systemic ﬂow is inade-
uate in immature lambs with shunts exceeding 50% of
eft ventricular output [22]. This leads to low diastolic
ortic pressure and decreased organ perfusion. Decreased
enal perfusion results in renal failure, aggravating volume
etention associated with congestive heart failure. Simi-
arly, impaired intestinal blood ﬂow and intestinal ischaemia
auses feeding intolerance and possibly necrotizing entero-
olitis.
iagnosis
ypical clinical ﬁndings, including a continuous or systolic
urmur, hyperactive precordium and bounding pulses, are
peciﬁc but not sensitive enough for PDA. Their appearance
s delayed compared with other ‘‘symptoms’’ of PDA that
eﬂect its haemodynamic consequences before cardiac
ailure develops. These symptoms are increased ventilatory
equirements 2 to 3 days after birth, which can sometimes
e difﬁcult to distinguish from the initial respiratory dis-
ress syndrome. Therefore, early presymptomatic reliable
iagnosis of PDA in the ﬁrst 4 days of life depends on ultra-
ound examination. Among the several potential markers,
olour Doppler measurement of the ductal diameter seems
o be most accurate in predicting a ‘‘haemodynamically
igniﬁcant’’ PDA requiring subsequent medical and/or
urgical intervention. In ventilated newborns within the
rst 30 hours of life, a ductus with left-to-right shunt and
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a diameter greater than 1.5mm predicts a signiﬁcant PDA
with a sensitivity of 81% and a speciﬁcity of 85% [23]. A
left atrial to aortic ratio > 1.5, left ventricular dilation,
diastolic pulsed Doppler ﬂow velocity in the left pulmonary
artery > 0.2m/sec and a retrograde diastolic ﬂow in the
descending aorta are very speciﬁc but occur later. However,
when present, they clearly indicate a haemodynamically
signiﬁcant PDA.
Therapeutic strategies
Ductal patency may be prevented antenatally by the mater-
nal administration of steroids and postnatally by avoidance
of excessive parenteral ﬂuid.
Medical treatment relies on cyclo-oxygenase inhibitors,
which were shown in the mid 1970s to close the duc-
tus successfully in about 80% of premature infants [24].
Indomethacin is the cyclo-oxygenase inhibitor that was ﬁrst
and most widely used. Adverse effects, mainly related to
the vasoconstrictor effect from inhibition of prostaglandin
synthesis, include transient renal failure [25] and gas-
trointestinal bleeding and perforation [26]. In contrast to
indomethacin, ibuprofen, a more recent cyclo-oxygenase
inhibitor, does not reduce cerebral, renal and intestinal
blood ﬂow. A meta-analysis of comparative trials has shown
that ibuprofen is as effective as indomethacin in closing
the ductus. Regarding side effects, there is no difference
in the incidence of necrotizing enterocolitis, but fewer
renal side effects with ibuprofen [27]. However, the clinical
signiﬁcance of this theoretical advantage is still debated.
There are no data available concerning long-term out-
come.
The best timing of medical treatment to prevent morbid-
ity remains highly controversial. Based on the assumption
that it might be wiser to treat the PDA before it has clin-
ical consequences, indomethacin has been given earlier
over the years. The most recently described strategy is
prophylactic treatment, consisting of indomethacin admin-
istration within the ﬁrst 24 hours of life to all extremely
premature infants. Although this approach reduces the inci-
dence of severe intraventricular haemorrhage and the need
for surgical ligation, it does not improve long-term neu-
rodevelopmental outcome [28]. Therefore, a prophylactic
strategy is not recommended because no clear bene-
ﬁt outweighs the unnecessary exposure to potential side
effects of infants that could have closed their ductus
spontaneously. Currently, the most widely used strategy
is early curative ‘‘presymptomatic’’ treatment, i.e. treat-
ment administration 2 to 3 days after birth to infants in
whom echocardiographic markers of a signiﬁcant PDA are
detected. However, some authors disagree strongly with
such an attitude and favour conservative management [29].
Surgical ligation can now be performed safely in the
neonatal unit in most centres when medical treatment has
failed or is contraindicated. In addition to the complications
of thoracotomy mentioned above, recent epidemiologic
studies have suggested that surgical ligation might increase
the likelihood of impaired neurodevelopmental outcome,
chronic lung disease and retinopathy of prematurity [30,31].
Therefore the beneﬁt/risk ratio of surgery should be
weighed carefully on an individual basis.
t
o
d583
uctus arteriosus and congenital heart
iseases
aemodynamics
n many congenital heart diseases, volume and oxygen
ontent of blood carried by the ductus during foetal life are
ltered markedly, resulting in modiﬁcations of its size, shape
nd ability to constrict [32].
Normally, the ductus arteriosus in the foetal lamb car-
ies about 55% of the CVO from the pulmonary artery to the
orta. It joins the aorta at an obtuse inferior angle, presum-
bly because ﬂow is directed down to the descending aorta
Fig. 3A).
In case of left-sided obstruction, a much larger propor-
ion of the output has to ﬂow through the ductus to maintain
normal CVO, resulting in a wider ductus (Fig. 3B). However,
ue to a mixture of systemic venous and umbilical venous
lood in the right atrium, the blood crossing the ductus arte-
iosus has a higher-than-normal oxygen saturation, inducing
uctal constriction.
In case of right-sided obstruction, the ductal shunt is
arkedly different from normal. First, the direction of the
hunt is reverted as blood ﬂows from the aorta to the pul-
onary artery to maintain pulmonary blood ﬂow. Second,
ulmonary blood ﬂow being only 5 to 10% of the CVO in the
oetus, the volume of blood crossing the ductus is lower than
ormal. The ductus arteriosus may thus be narrower and
ts connection with the aorta has an acute inferior angle
Fig. 3C). Third, the blood crossing the ductus arteriosus
as higher oxygen saturation because all systemic venous,
mbilical venous and pulmonary venous blood mixes in the
eft atrium. This higher oxygen saturation induces ductal
onstriction.
In case of transposition of the great arteries, the pul-
onary artery, and thus the ductus arteriosus, receive
lood with high oxygen saturation ejected from the
eft ventricle. This could induce ductal constriction and
ncrease pulmonary blood ﬂow. In addition, the satura-
ion of the blood ﬂowing through the foetal pulmonary
irculation is increased, initially lowering pulmonary vas-
ular resistance and further increasing pulmonary blood
ow. Secondarily, pulmonary blood ﬂow decreases by a
yogenic reﬂex-mediated mechanism, and remodelling of
ulmonary arterioles occurs. These mechanisms could partly
xplain the increased incidence of persistent pulmonary
ypertension in newborns with transposition of the great
rteries.
After birth, ductal closure is frequently delayed in con-
enital heart defects. In cyanotic infants, the arterial
O2 may not be sufﬁcient to stimulate ductal cons-
riction. In infants with left-sided obstructive lesions,
O2 increases signiﬁcantly after birth. However, due to
ight-to-left shunting, the ductus is exposed to mixed
enous saturation and therefore to less oxygen stimulus
o constrict. In addition, in these infants, high pulmonary
rterial pressure and high ductal ﬂow may contribute
o maintain its patency. However, the ductus does tend
o constrict after a few days, compromising systemic
r pulmonary blood ﬂow in infants with duct-dependent
efects.
584
Figure 3. Relationships and sizes of the ductus arteriosus and the
aorta, pulmonary trunk and pulmonary arteries. A: in a normal foe-
tus. B: in a foetus with aortic atresia. C: in a foetus with pulmonary
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aintenance of ductal patency
he use of intravenous alprostadil (PGE1) to maintain duc-
al patency improved dramatically the management of
ewborns with duct-dependent congenital heart defects
n the early 1980s [33]. It is usually very effective when
iven shortly after ductal constriction. The frequency of
he most usual side effects, such as hypotension, apnoea,
ever and pain, can be reduced greatly by using doses
[V. Gournay
0.01g/kg/min [34]. Other less frequent side effects,
ncluding gastric outlet obstruction and cortical hyperosto-
is, occur only after prolonged administration.
Concerns about the complications of long-term
rostaglandin infusion have led physicians to seek alter-
ative means to maintain ductal patency, speciﬁcally
n the setting of hypoplastic left heart syndrome. The
oma Linda group, who had the greatest experience in
he management of neonates waiting for transplantation,
eported a promising preliminary experience of ductal
tenting in ﬁve patients in 1993 [35]. Subsequently, other
nvestigators concluded that although the ductal stent
an be placed safely and does maintain ductal patency,
ubsequent pulmonary overcirculation is a major problem.
More recently, ductal stenting has also been applied as
art of a hybrid catheter-surgical univentrical palliation
trategy in patients with hypoplastic left heart syndrome
36]. The objective of this procedure, which combines per-
utaneous ductal stenting and surgical pulmonary artery
anding, is to improve survival in patients who are consid-
red at too high risk for the stage I Norwood intervention.
he latest results reported a 50% survival rate, which is simi-
ar to the current results for the conventional Norwood stage
operation in similarly high-risk patients [37].
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